BICYCLE THERAPEUTICS PLC Quarterly Income Tax Expense (Benefit) in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Bicycle Therapeutics Plc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2018 to Q2 2024.
  • Bicycle Therapeutics Plc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $115K.
  • Bicycle Therapeutics Plc Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $2.36M.
  • Bicycle Therapeutics Plc annual Income Tax Expense (Benefit) for 2023 was $1.46M.
  • Bicycle Therapeutics Plc annual Income Tax Expense (Benefit) for 2022 was -$1.52M, a 8.36% increase from 2021.
  • Bicycle Therapeutics Plc annual Income Tax Expense (Benefit) for 2021 was -$1.66M, a 130% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.36M $115K +$632K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $1.73M -$350K +$268K +43.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $1.46M $320K +$740K Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $717K $2.27M +$2.51M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$1.79M -$517K -$70K -15.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$1.72M -$618K -$199K -47.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$1.52M -$420K +$328K +43.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 -$1.85M -$238K +$177K +42.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$2.03M -$447K -$287K -179% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$1.74M -$419K -$79K -23.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$1.66M -$748K -$693K -1260% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 -$970K -$415K +$50K +10.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$1.02M -$160K -$63K -64.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$957K -$340K -$233K -218% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$724K -$55K +$83K +60.1% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-11
Q3 2020 -$807K -$465K -$134K -40.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$673K -$97K -$232K -172% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$441K -$107K -$187K -234% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$254K -$138K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$331K -$331K Jul 1, 2019 Sep 30, 2019 10-K 2021-03-11
Q2 2019 $135K Apr 1, 2019 Jun 30, 2019 10-K 2021-03-11
Q1 2019 $80K +$476K Jan 1, 2019 Mar 31, 2019 10-K 2021-03-11
Q3 2018 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q1 2018 -$396K Jan 1, 2018 Mar 31, 2018 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.